Top Legislation - View All
Also tagged in: Actions and defenses, Administrative procedure, Administrative remedies, Advice and consent of the Senate, Agricultural extension work, Agricultural research, Agriculture, Agriculture in foreign trade, Animal diseases, Animals, Armed forces, Auditing, Biological warfare, Bribery, Business, Business records, Citizen lawsuits, Civil rights, Congressional reporting requirements, Consumer complaints, Consumer education, Consumers, Criminal justice, Criminal liability, Damages, Data banks, Defective products, Defense policy, Department of Agriculture, Department of Commerce, Department of Health and Human Services, Department of Labor, Disciplining of employees, Discrimination in employment, Dismissal of employees, DNA, Drug resistance in microorganisms, Employee training, Environmental protection, Environmental Protection Agency, Epidemiology, Executive departments, Executive reorganization, Export controls, Federal advisory bodies, Federal employees, Federal-local relations, Federal-state relations, Feeds, Fines (Penalties), Food, Food and Drug Administration (FDA), Food industry, Food safety, Food supply, Foodborne diseases, Foreign policy, Fraud, Gifts, Government employees, Government information, Government paperwork, Government publicity, Governmental investigations, Grocery trade, Hazardous substances, Health education, Health surveys, Import restrictions, Imports, Injunctions, International affairs, Job training, Labeling, Labor, Laboratories, Law, Legal fees, Licenses, Limitation of actions, Meat inspection, Medical care, Medical research, Medical statistics, Medicine, Nutrition, Pesticides, Physical examinations, Plants, Poultry, Presidential appointments, Presidents, Preventive medicine, Retail trade, Science policy, Seafood, Searches and seizures, Standards, State and local government, State employees, Storage, Technology, Terrorism, Trade, Veterinary medicine, Wage restitution, Whistle blowing
Latest Action: 02/15/2007 - Sponsor introductory remarks on measure. (CR S2101) Bill TextA bill to establish the Food Safety Administration to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination, and for other purposes. 2/15/2007--Introduced. Safe Food Act of 2007 - Establishes the Food Safety Administration to administer and enforce food safety laws. Directs the Administrator of the Food Safety Administration to: (1) promulgate regulations to ensure the security of the food supply from all forms of contamination; (2) implement federal food safety inspection, enforcement, and research efforts to protect the public health; (3) develop consistent and science-based standards for safe food; and (4) prioritize federal food safety efforts and deployment of resources to achieve the greatest possible benefit in reducing food-borne illness. Transfers to the Administration all functions of specified federal [...] show full description
Also tagged in: Agriculture, Animal diseases, Animals, Business, Business records, Consumers, Drug approvals, Drug industry, Drug resistance in microorganisms, Drugs, Food, Food safety, Government information, Government paperwork, Government publicity, Livestock, Medical care, Medicated feeds, Medicine, Pharmaceutical research, Science policy, Veterinary medicine
Latest Action: 02/09/2007 - Referred to the Subcommittee on Health. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. 2/8/2007--Introduced. Preservation of Antibiotics for Medical Treatment Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms. Requires the Secretary to withdraw approval of a nontherapeutic use of such drugs in food-producing [...] show full description
Also tagged in: Authorization, Biological warfare, Budgets, Chemical warfare, Counterterrorism, Criminal justice, Department of Homeland Security, Drugs, Emergency management, Emergency medicine, Executive departments, Health policy, Medical care, Medicine, Nuclear terrorism, Public health, Risk, Terrorism, Vaccines
Latest Action: 02/23/2007 - Referred to the Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology. Bill TextTo amend the Public Health Service Act to require the Secretary of Homeland Security to improve and expedite the assessment and determination of current and emerging chemical, biological, radiological and nuclear material threats, to group such agents to facilitate the assessment and acquisition of countermeasures that would address more than one of such agents or adverse health consequences common to exposure to different agents, and for other purposes. 2/15/2007--Introduced. Project Bioshield Material Threats Act of 2007 - Amends the Public Health Service Act to require the Secretary of Homeland Security (the Secretary) to utilize existing risk assessments to assess current and emerging threats of chemical, biological, radiological, and nuclear agents and determine which of such agents present a material threat against the U.S. population sufficient to affect national security. Requires the Secretary to group such assessments to facilitate assessments by the Secretary of [...] show full description
Also tagged in: Abortion, Actions and defenses, Administrative fees, Administrative procedure, Agriculture, Agriculture in foreign trade, Animals, Biomedical engineering, Budgets, Business, Canada, Cancer, Chemotherapy, Child health, Children, Clinical trials, Communicable diseases, Communication in medicine, Communications, Conflict of interests, Congress, Congressional investigations, Congressional oversight, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Counterfeiting, Criminal justice, Data banks, Defective products, Department of Health and Human Services, Drug abuse, Drug adulteration, Drug approvals, Drug industry, Drug interactions, Drug law enforcement, Drug therapy, Drug utilization, Drugs, Education, Electronic data interchange, Elementary and secondary education, Environmental protection, Executive departments, Eye diseases, Families, Federal advisory bodies, Federal aid to education, Federal aid to research, Federal reserve system, Fines (Penalties), Food, Food additives, Food and Drug Administration (FDA), Food industry, Food preservation, Food safety, Food supply, Foodborne diseases, Foundations, Fraud, Generic drugs, Genetic counseling, Genetic engineering, Genetics, Government information, Government paperwork, Government publicity, Hazardous substances, Health information systems, Health surveys, Health warnings, Higher education, Imaging systems in medicine, Import restrictions, Intellectual property, Internet, Labeling, Law, Marijuana, Meat, Medical care, Medical education, Medical instruments and apparatus, Medical laboratories, Medical records, Medical statistics, Medical supplies, Medicinal plants, Medicine, Orphan drugs, Packaging, Parent and child, Parental consent, Patent infringement, Pediatrics, Pesticides, Pets, Pharmaceutical research, Pharmacists, Physical examinations, Politics and government, Preschool education, Prescription pricing, Prices, Produce trade, Product development, Product safety, Protection of animals, Public meetings, Research and development, Research grants, Restrictive trade practices, Risk, Salmonella, Scholarships, Science policy, Seafood, Shellfish, Skin cancer, Skin diseases, Small business, Social services, Strategic planning, Student loan funds, Technology, Telecommunication, Trade, Turtles, User charges, Web sites
Latest Action: 05/10/2007 - Received in the House. Bill TextAn act to amend the Federal Food, Drug, and cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products, and for other purposes. 5/9/2007--Passed Senate amended. (There are 2 other summaries) Food and Drug Administration Revitalization Act - Title I: Prescription Drug User Fees - (Sec. 101) - Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to set forth as a purpose that authorized prescription drug fees be dedicated toward expediting the drug development process, the process for the review of human drug applications, and postmarket drug safety. Sets forth reporting requirements, including requiring the Secretary of Human Services (the Secretary) to present to Congress recommendations developed for achieving certain goals for the review process of human drug applications and for reauthorization of user [...] show full description
Also tagged in: Administrative remedies, Business, Child health, Children, Clinical trials, Consumer education, Consumers, Department of Health and Human Services, Drug approvals, Drug industry, Drug utilization, Executive departments, Generic drugs, Intellectual property, Labeling, Law, Marketing, Medical care, Medicine, Patent infringement, Patents, Pediatrics, Prescription pricing
Latest Action: 04/11/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for certain drugs, and for other purposes. 4/11/2007--Introduced. Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act or the Lower PRICED Drugs Act - Amends the Federal Food, Drug, and Cosmetic Act to require an abbreviated application for a new drug containing certain antibiotics, the approved labeling for which includes a method of use that is claimed by a patent, to include a statement: (1) that identifies the relevant patent and the approved use covered by the patent; and (2) that the applicant is not seeking approval of such use. Requires the court to consider the totality of circumstances and the public interest in deciding whether to shorten the 30-month period that delays the approval of an abbreviated drug application when a patent infringement case is filed against the applicant. Limits market exclusivity provided for conducting [...] show full description
Also tagged in: Actions and defenses, Administrative procedure, Administrative remedies, Advice and consent of the Senate, Agricultural extension work, Agricultural research, Agriculture, Agriculture in foreign trade, Animal diseases, Animals, Armed forces, Auditing, Biological warfare, Bribery, Business, Business records, Citizen lawsuits, Civil rights, Congressional reporting requirements, Consumer complaints, Consumer education, Consumers, Criminal justice, Criminal liability, Damages, Data banks, Defective products, Defense policy, Department of Agriculture, Department of Commerce, Department of Health and Human Services, Department of Labor, Disciplining of employees, Discrimination in employment, Dismissal of employees, DNA, Drug resistance in microorganisms, Employee training, Environmental protection, Environmental Protection Agency, Epidemiology, Executive departments, Executive reorganization, Export controls, Federal advisory bodies, Federal employees, Federal-local relations, Federal-state relations, Feeds, Fines (Penalties), Food, Food and Drug Administration (FDA), Food industry, Food safety, Food supply, Foodborne diseases, Foreign policy, Fraud, Gifts, Government employees, Government information, Government paperwork, Government publicity, Governmental investigations, Grocery trade, Hazardous substances, Health education, Health surveys, Import restrictions, Imports, Injunctions, International affairs, Job training, Labeling, Labor, Laboratories, Law, Legal fees, Licenses, Limitation of actions, Meat inspection, Medical care, Medical research, Medical statistics, Medicine, Nutrition, Pesticides, Physical examinations, Plants, Poultry, Presidential appointments, Presidents, Preventive medicine, Retail trade, Science policy, Seafood, Searches and seizures, Standards, State and local government, State employees, Storage, Technology, Terrorism, Trade, Veterinary medicine, Wage restitution, Whistle blowing
Latest Action: 02/27/2007 - Referred to the Subcommittee on Health. Bill TextTo establish the Food Safety Administration to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination, and for other purposes. 2/16/2007--Introduced. Safe Food Act of 2007 - Establishes the Food Safety Administration to administer and enforce food safety laws. Directs the Administrator of the Food Safety Administration to: (1) promulgate regulations to ensure the security of the food supply from all forms of contamination; (2) implement federal food safety inspection, enforcement, and research efforts to protect the public health; (3) develop consistent and science-based standards for safe food; and (4) prioritize federal food safety efforts and deployment of resources to achieve the greatest possible benefit in reducing food-borne illness. Transfers to the Administration all functions of specified federal [...] show full description
Also tagged in: Administrative procedure, Biotechnology, Business, Clinical trials, Communicable diseases, Congressional reporting requirements, Department of Health and Human Services, Drug approvals, Drug industry, Drug resistance in microorganisms, Executive departments, Executive reorganization, Federal advisory bodies, Food and Drug Administration (FDA), Government information, Government paperwork, Health policy, Income tax, Influenza, Intellectual property, Investment tax credit, Law, Medical care, Medical tests, Medicine, Patents, Pharmaceutical research, Public health, Research and development, Research and development tax credit, Science policy, Small business, State and local government, State laws, Surveys, Tax administration, Taxation, Technology, Vaccines
Latest Action: 04/20/2007 - Referred to the Subcommittee on Courts, the Internet, and Intellectual Property. Bill TextTo provide incentives for pharmaceutical companies, biotechnology companies, and medical device companies to invest in research and development with respect to antibiotic drugs, antivirals, diagnostic tests, and vaccines that may be used to identify, treat, or prevent serious and life-threatening infectious diseases. 3/13/2007--Introduced. Beating Infections through Research and Development Act of 2007 - Sets forth circumstances under which the term of a patent may be extended for qualified infectious disease products.Requires the Secretary of Health and Human Services to designate qualified infectious disease products as fast-track products for approval.Amends the Public Health Service Act to require the Director of the National Institute of Allergy and Infectious Diseases to expand and intensify efforts to assist small manufacturers to conduct end-stage clinical trials on qualified infectious disease products.Amends the Internal Revenue Code to establish [...] show full description
Also tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Animals, Authorization, Budgets, Business, Cancer, Child health, Children, Civil liberties, Clinical trials, Communications, Computer security measures, Conflict of interests, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Data banks, Deceptive advertising, Department of Health and Human Services, Directories, Drug advertising, Drug approvals, Drug industry, Drug interactions, Drugs, Electronic data interchange, Electronic government information, Executive departments, Executive reorganization, Federal advisory bodies, Federal aid to research, Food, Food and Drug Administration (FDA), Food safety, Foreign corporations, Foundations, Fund raising, Gifts, Government information, Government paperwork, Government publicity, Health information systems, Health policy, Identification devices, Imaging systems in medicine, Imports, Intellectual property, Inventions, Inventors, Labeling, Law, Licenses, Medical care, Medical ethics, Medical innovations, Medical instruments and apparatus, Medical records, Medical research, Medical supplies, Medicine, National Institutes of Health (NIH), Nonprofit organizations, Nosocomial infections, Nuclear medicine, Orphan drugs, Patents, Pediatrics, Performance measurement, Pharmaceutical research, Physicians, Product counterfeiting, Product development, Product safety, Profit, Public-private partnerships, Research and development, Research grants, Right of privacy, Risk, Science policy, Small business, Social services, Technology, Telecommunication, Telephone, Television advertising, Trade, User charges, Veterinary medicine
Latest Action: 07/16/2007 - Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 270. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. 7/11/2007--Passed House amended. (There is 1 other summary) Food and Drug Administration Amendments Act of 2007 - Title I: Prescription Drug User Fee Amendments of 2007 - (Sec. 101) Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to include postmarket safety activities within the process for the review of human drug applications or supplements, including: (1) developing and using improved adverse event data collection systems and improved analytical tools to assess potential safety problems; (2) implementing and enforcing provisions relating to postapproval studies, clinical trials, labeling changes, and risk [...] show full description
Also tagged in: Agricultural subsidies, Agriculture, Animals, Business, Business records, Consumers, Drug approvals, Drug industry, Drug resistance in microorganisms, Drugs, Families, Family farms, Food, Food safety, Government information, Government paperwork, Health policy, Livestock, Meat, Medical care, Medicated feeds, Medicine, Poultry, Small farms, Veterinary medicine
Latest Action: 02/12/2007 - Sponsor introductory remarks on measure. (CR S1853-1854) Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. 2/12/2007--Introduced. Preservation of Antibiotics for Medical Treatment Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms.Requires the Secretary of Health and Human Services to withdraw approval of a nontherapeutic [...] show full description
Also tagged in: Commemorations, Communicable diseases, Drug resistance in microorganisms, Health education, Hospitals, Medical care, Medical research, Medicine, Pharmaceutical research, Preventive medicine, Science policy, Special months
Latest Action: 02/14/2008 - Sponsor introductory remarks on measure. (CR S1072-1073) Bill TextA resolution designating the month of March 2008 as "MRSA Awareness Month". 2/14/2008--Introduced. Designates March 2008 as MRSA Awareness Month. Recognizes: (1) the need to apply what is already known about reducing the transmission of infections in hospitals, effectively using diagnostics, and ensuring appropriate use of antibiotics to meet patient and public health needs; (2) the need to pursue operational research to find the best ways of preventing hospital- and community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) and developing new antibiotics for improving care for MRSA patients; and (3) the importance of raising awareness of MRSA and methods of preventing MRSA infections. Expresses support for the work of advocates, healthcare practitioners, and science-based experts in educating, supporting, and providing hope for individuals and their families affected by community and healthcare associated infections.
|
Latest Legislation - View All
Also tagged in: Commemorations, Communicable diseases, Drug resistance in microorganisms, Health education, Hospitals, Medical care, Medical research, Medicine, Pharmaceutical research, Preventive medicine, Science policy, Special months
Latest Action: 02/14/2008 - Sponsor introductory remarks on measure. (CR S1072-1073) Bill TextA resolution designating the month of March 2008 as "MRSA Awareness Month". 2/14/2008--Introduced. Designates March 2008 as MRSA Awareness Month. Recognizes: (1) the need to apply what is already known about reducing the transmission of infections in hospitals, effectively using diagnostics, and ensuring appropriate use of antibiotics to meet patient and public health needs; (2) the need to pursue operational research to find the best ways of preventing hospital- and community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) and developing new antibiotics for improving care for MRSA patients; and (3) the importance of raising awareness of MRSA and methods of preventing MRSA infections. Expresses support for the work of advocates, healthcare practitioners, and science-based experts in educating, supporting, and providing hope for individuals and their families affected by community and healthcare associated infections.
Also tagged in: Commemorations, Communicable diseases, Drug resistance in microorganisms, Health education, Hospitals, Medical care, Medical research, Medicine, Pharmaceutical research, Preventive medicine, Science policy, Special months
Latest Action: 02/14/2008 - Referred to the House Committee on Energy and Commerce. Bill TextDesignating the month of March 2008 as "MRSA Awareness Month". 2/14/2008--Introduced. Recognizes: (1) the need to apply what is known about reducing the transmission of infections in hospitals and assuring appropriate use of antibiotics to meet patient and public health needs; (2) the need to pursue operational research on preventing hospital- and community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) and developing new antibiotics for improving care for MRSA patients; and (3) the importance of raising awareness of MRSA and methods of preventing MRSA infections. Expresses support for the work of advocates, healthcare practitioners, and science-based experts in educating, supporting, and providing hope for individuals and their families affected by community and healthcare associated infections.
Also tagged in: Administrative procedure, Aged, Communicable diseases, Department of Health and Human Services, Drug resistance in microorganisms, Executive departments, Government information, Government paperwork, Health information systems, Health policy, Hospital care, Hospital rates, Hospitals, Law, Medical care, Medical records, Medical screening, Medical statistics, Medicare, Medicine, Preventive medicine
Latest Action: 12/19/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to prevent health care facility-acquired infections. 12/19/2007--Introduced. MRSA Infection Prevention and Patient Protection Act - Directs the Secretary of Health and Human Services to promulgate regulations that: (1) define "MRSA" (methicillin-resistant staphylococcus aureus); (2) provide a list of best practices for antibiotic resistant staphylococcus; (3) define "high risk hospital departments" for purposes of applying such practices; and (4) provide screening, recordkeeping, and other requirements as they relate to MRSA reductions. Requires acute care hospitals to screen patients entering intensive care units and other high risk hospital departments. Directs the Secretary to: (1) establish a process and a timetable for extending the screening requirements to patients admitted to all hospitals by January 1, 2012, subject to a waiver; and (2) report to Congress, by January 1, 2009, on whether payment adjustments should be made under Medicare [...] show full description
Also tagged in: Administrative procedure, Communicable diseases, Criminal justice, Department of Health and Human Services, Department of Labor, Drug resistance in microorganisms, Emergency management, Emergency medicine, Employee training, Executive departments, Fire fighters, Health surveys, Influenza, Job training, Law, Medical care, Medical personnel, Medicine, Occupational health and safety, Police, Rescue work, Standards, Vaccines
Latest Action: 12/19/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to protect health care workers and first responders, including police, fire-fighters, emergency medical personnel, and other workers at risk of workplace exposure to infectious agents and drug resistant infections, such as MRSA and pandemic influenza. 12/19/2007--Introduced. Worker Infection Protection Act - Directs the Secretaries of Labor and of Health and Human Services (HHS) to jointly develop and issue workplace standards, recommendations, and plans to protect health care workers and first responders and other workers at risk of workplace exposure to infectious agents and drug resistant infections, such as Methicillin-resistant Staphylococcus aureus (MRSA) and pandemic influenza.Directs the Secretary of Labor to develop and issue an emergency temporary standard and, not later than six months after such issuance, a permanent standard for the protection of workers at risk of exposure, to prevent occupational exposure to infectious agents and toxins, such as [...] show full description
Also tagged in: Business, Communicable diseases, Drug industry, Income tax, Medical care, Medical tests, Medicine, Pharmaceutical research, Preventive medicine, Research and development tax credit, Science policy, Taxation, Vaccines, Virus diseases
Latest Action: 11/15/2007 - Referred to the House Committee on Ways and Means. Bill TextTo amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products. 11/15/2007--Introduced. Amends the Internal Revenue Code to allow a general business tax credit for 50% of expenses paid for research and development of any qualified infectious disease product. Defines "qualified infectious disease product" as any antibiotic drug, antiviral, diagnostic test, biological product, or vaccine developed to treat, detect, prevent, or identify certain pathogens. Terminates such credit after 2012.
Also tagged in: Business, Communicable diseases, Drug industry, Income tax, Medical care, Medical tests, Medicine, Pharmaceutical research, Preventive medicine, Research and development tax credit, Science policy, Taxation, Vaccines, Virus diseases
Latest Action: 11/14/2007 - Read twice and referred to the Committee on Finance. Bill TextA bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products. 11/14/2007--Introduced. Amends the Internal Revenue Code to allow a general business tax credit for 50% of expenses paid for research and development of any qualified infectious disease product. Defines "qualified infectious disease product" as any antibiotic drug, antiviral, diagnostic test, biological product, or vaccine developed to treat, detect, prevent, or identify certain pathogens. Terminates such credit after 2012.
Also tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Agriculture, Animals, Aquaculture, Authorization, Authors and authorship, Budgets, Business, Child health, Children, Civil liberties, Clinical trials, Communicable diseases, Communication in medicine, Communication in science, Communications, Conflict of interests, Congress, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Criminal justice, Criminal justice information, Data banks, Deceptive advertising, Department of Health and Human Services, Direct mail advertising, Directories, Drug advertising, Drug approvals, Drug industry, Drug resistance in microorganisms, Drugs, Electronic data interchange, Electronic government information, Emergency communication systems, Emergency management, Employee training, Environmental assessment, Environmental protection, Executive departments, Executive reorganization, Eye diseases, Federal advisory bodies, Federal employees, Federal officials, Federal preemption, Financial disclosure, Fines (Penalties), Food and Drug Administration (FDA), Food labeling, Food safety, Foundations, Fund raising, Generic drugs, Genetic engineering, Genetic research, Gifts, Government employees, Government information, Government paperwork, Government publicity, Grants-in-aid, Hazardous substances, Health information systems, Health policy, Health surveys, Humanities, Identification devices, Imports, Intellectual property, Internet, Inventors, Job training, Labeling, Law, Local laws, Medical associations, Medical care, Medical ethics, Medical instruments and apparatus, Medical supplies, Medicine, Nonprofit organizations, Nosocomial infections, Orphan drugs, Patents, Pediatrics, Peer review organizations (Medicine), Performance measurement, Pesticides, Pharmaceutical research, Physicians, Product counterfeiting, Product development, Product safety, Public contracts, Public meetings, Public-private partnerships, Radioisotopes in medicine, Research and development, Research grants, Right of privacy, Risk, Science policy, Scientists in government, Seafood, Skin cancer, Small business, Social services, Standards, State and local government, State laws, Technology, Telecommunication, Television advertising, Terrorism, Trade, Trade agreements, Trade negotiations, User charges, Veterinary medicine, Warning labels
Latest Action: 09/27/2007 - Signed by President. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. 9/27/2007--Public Law. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)Food and Drug Administration Amendments Act of 2007 - Title I: Prescription Drug User Fee Amendments of 2007 - (Sec. 101) Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to include postmarket safety activities within the process for the review of human drug applications or supplements, including: (1) developing and using improved adverse event data collection systems and improved analytical tools to assess potential [...] show full description
Also tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Animals, Authorization, Budgets, Business, Cancer, Child health, Children, Civil liberties, Clinical trials, Communications, Computer security measures, Conflict of interests, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Data banks, Deceptive advertising, Department of Health and Human Services, Directories, Drug advertising, Drug approvals, Drug industry, Drug interactions, Drugs, Electronic data interchange, Electronic government information, Executive departments, Executive reorganization, Federal advisory bodies, Federal aid to research, Food, Food and Drug Administration (FDA), Food safety, Foreign corporations, Foundations, Fund raising, Gifts, Government information, Government paperwork, Government publicity, Health information systems, Health policy, Identification devices, Imaging systems in medicine, Imports, Intellectual property, Inventions, Inventors, Labeling, Law, Licenses, Medical care, Medical ethics, Medical innovations, Medical instruments and apparatus, |
